Androgen receptor YAC Transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration

被引:148
作者
Sopher, BL
Thomas, PS
LaFevre-Bernt, MA
Holm, IE
Wilke, SA
Ware, CB
Jin, LW
Libby, RT
Ellerby, LM
La Spada, AR [1 ]
机构
[1] Univ Washington, Ctr Med, Dept Lab Med, Seattle, WA 98195 USA
[2] Univ Washington, Ctr Med, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Washington, Ctr Med, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Ctr Med, Dept Med Med Genet, Seattle, WA 98195 USA
[5] Univ Washington, Ctr Med, Dept Neurol Neurogenet, Seattle, WA 98195 USA
[6] Buck Inst Age Res, Novato, CA 94945 USA
关键词
D O I
10.1016/S0896-6273(04)00082-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
X-linked spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder characterized by lower motor neuron degeneration. SBMA is caused by polyglutamine repeat expansions in the androgen receptor (AR). To determine the basis of AR polyglutamine neurotoxicity, we introduced human AR yeast artificial chromosomes carrying either 20 or 100 CAGs into mouse embryonic stem cells. The AR100 transgenic mice developed a late-onset, gradually progressive neuromuscular phenotype accompanied by motor neuron degeneration, indicating striking recapitulation of the human disease. We then tested the hypothesis that polyglutamine-expanded AR interferes with CREB binding protein (CBP)-mediated transcription of vascular endothelial growth factor (VEGF) and observed altered CBP-AR binding and VEGF reduction in AR100 mice. We found that mutant AR-induced death of motor neuron-like cells could be rescued by VEGF. Our results suggest that SBMA motor neuronopathy involves altered expression of VEGF, consistent with a role for VEGF as a neurotrophic/survival factor in motor neuron disease.
引用
收藏
页码:687 / 699
页数:13
相关论文
共 47 条
  • [1] Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
    Abel, A
    Walcott, J
    Woods, J
    Duda, J
    Merry, DE
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (02) : 107 - 116
  • [2] Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death
    Adachi, H
    Kume, A
    Li, M
    Nakagomi, Y
    Niwa, H
    Do, J
    Sang, C
    Kobayashi, Y
    Doyu, M
    Sobue, G
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (10) : 1039 - 1048
  • [3] A FAMILY WITH ADULT SPINAL AND BULBAR MUSCULAR-ATROPHY, X-LINKED INHERITANCE AND ASSOCIATED TESTICULAR FAILURE
    ARBIZU, T
    SANTAMARIA, J
    GOMEZ, JM
    QUILEZ, A
    SERRA, JP
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 59 (03) : 371 - 382
  • [4] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [5] Transgenic models of Huntington's disease
    Bates, GP
    Mangiarini, L
    Mahal, A
    Davies, SW
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (10) : 1633 - 1637
  • [6] Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α
    Carrero, P
    Okamoto, K
    Coumailleau, P
    O'Brien, S
    Tanaka, H
    Poellinger, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) : 402 - 415
  • [7] Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
    Crawley, JN
    [J]. BRAIN RESEARCH, 1999, 835 (01) : 18 - 26
  • [8] Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response
    Dames, SA
    Martinez-Yamout, M
    De Guzman, RN
    Dyson, HJ
    Wright, PE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) : 5271 - 5276
  • [9] Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
    Dunah, AW
    Jeong, H
    Griffin, A
    Kim, YM
    Standaert, DG
    Hersch, SM
    Mouradian, MM
    Young, AB
    Tanese, N
    Krainc, D
    [J]. SCIENCE, 2002, 296 (5576) : 2238 - 2243
  • [10] The biology of VEGF and its receptors
    Ferrara, N
    Gerber, HP
    LeCouter, J
    [J]. NATURE MEDICINE, 2003, 9 (06) : 669 - 676